{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-190006","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2022-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.145453+00:00","generated_at":"2026-06-24T18:37:43.564680+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Kymera appoints Leigh Morgan to Board of Directors and Compensation Committee","bullets":["Leigh Morgan appointed as Class II director effective July 6, 2022; term expires at 2025 annual meeting.","Board determined she is independent under Nasdaq listing standards.","Ms. Morgan also appointed to Compensation Committee; committee now includes Morgan, Albers, Maraganore, Nicholson.","She will receive standard non-employee director compensation; no material transactions disclosed.","No changes to Audit or Nominating and Corporate Governance Committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-190006","json":"https://secwatch.observer/filing/0001193125-22-190006.json","markdown":"https://secwatch.observer/filing/0001193125-22-190006.md","text":"https://secwatch.observer/filing/0001193125-22-190006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312522190006/0001193125-22-190006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312522190006/d550029d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T18:37:43.564680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a897fd8ec4","claim":"Leigh Morgan was appointed as Director at Kymera Therapeutics, Inc..","evidence_excerpt":"the Board appointed Leigh Morgan to join the Board, effective as of July 6, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312522190006/0001193125-22-190006-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}